Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape

BenzingaFeb 12 16:41 ET

$THRD Stock Is up 17% Today. Here's What We See in Our Data.

Quiver QuantitativeFeb 12 10:31 ET

Morgan Stanley Maintains Third Harmonic Bio(THRD.US) With Hold Rating, Maintains Target Price $5

Moomoo NewsFeb 12 10:31 ET · Ratings

Third Harmonic Bio Price Target Cut to $5.00/Share From $20.00 by Morgan Stanley

Dow JonesFeb 12 04:22 ET · Ratings

Third Harmonic Bio Cut to Equal-Weight From Overweight by Morgan Stanley

Dow JonesFeb 12 04:22 ET · Ratings

Morgan Stanley Downgrades Third Harmonic Bio(THRD.US) to Hold Rating, Cuts Target Price to $5

Moomoo NewsFeb 11 16:31 ET · Ratings